Testing the New AAHP Disclaimer for Effectiveness
By Jeremy Kees, PhD, Professor, Marketing & Business Law and Faculty Director, Villanova University February 1, 2018 The American Association of Homeopathic Pharmacists (AAHP) enlisted my assistance in 2017 to…
Read MoreAAHP Shares FDA’s Commitment to Protecting Public Health
December 19, 2017 In response to the U.S. Food and Drug Administration’s (FDA) draft guidance on homeopathic drug products released on Monday, December 18, 2017, the American Association of Homeopathic Pharmacists offers…
Read MoreArnica montana: A Clinical Snapshot
By Todd Hoover, MD December 11, 2017 Arnica montana has been used for centuries as a phytomedicine for its analgesic and anti-inflammatory properties. Commonly known as Wolf’s bane or Leopard’s…
Read More2017 Year in Review
2017 was a busy year for AAHP. With a new administration in the White House and key legislative issues heating up, the association had a full plate. But together with…
Read MoreSteps Toward Building Grassroots Support
December 6, 2017 Since the FDA hearing and the FTC workshop in 2015, the homeopathic industry has received more attention than usual from regulators. While AAHP continually meets with congressional…
Read MoreRecall Preparedness
By Mark Land, AAHP president November 20, 2017 Risks associated with the therapeutic use of healthcare products are real. Manufacturers and the U.S. Food and Drug Administration (FDA) balance these…
Read MoreUpcoming Webinar to Highlight Homeopathic Drug Stability
MILWAUKIE, Ore. (Nov. 14, 2017) – The American Association of Homeopathic Pharmacists (AAHP) will host a two-part webinar series on stability studies for homeopathic drug products. Slated for Dec. 4…
Read MoreAnnual Certification of Drug Product Listings
By Leonard Krause, FDA Connect November 1, 2017 It is that time of year again. Days are getting shorter and colder, and AAHP members who manufacture homeopathic and over-the-counter (OTC)…
Read MoreNew Drug Listing Requirement and Timetable Effective this Month
By Eric Foxman, AAHP Secretary October 1, 2017 The FDA recently introduced new requirements for the annual drug product reporting period and a new Structured Product Labeling (SPL) submission type.…
Read MoreThe Long-Term Vision for AAHP
By Eric Foxman, AAHP secretary October 1, 2017 During the course of the summer, AAHP president Mark Land lead the various association committees in an intense introspective series of meetings…
Read More